SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder
16 references·12 citing·39 second hop
A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder (2004)A Double-Blind, Placebo-Controlled Study …Venlafaxine Extended Release (ER) in the Treatment of Generalised Anxiety Disorder (2001)Venlafaxine Extended Release …Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study (2001)Sertraline Treatment of Gener…Impact of Generalized Social Anxiety Disorder in Managed Care (2001)Impact of Generalized Social …Efficacy of Venlafaxine Extended-Release Capsules in Nondepressed Outpatients With Generalized Anxiety Disorder (2000)Efficacy of Venlafaxine Exten…Efficacy of Extended-Release Venlafaxine in Nondepressed Outpatients With Generalized Anxiety Disorder (2000)Efficacy of Extended-Release …The functional anatomy, neurochemistry, and pharmacology of anxiety. (1999)The functional anatomy, neuro…Fluvoxamine Treatment of Social Phobia (Social Anxiety Disorder): A Double-Blind, Placebo-Controlled Study (1999)Fluvoxamine Treatment of Soci…Efficacy, Safety, and Tolerability of Venlafaxine Extended Release and Buspirone in Outpatients With Generalized Anxiety Disorder (1999)Efficacy, Safety, and Tolerab…Social Phobia Subtypes in the National Comorbidity Survey (1998)Social Phobia Subtypes in the…Paroxetine Treatment of Generalized Social Phobia (Social Anxiety Disorder) (1998)Paroxetine Treatment of Gener…Social Phobia in General Health Care: An Unrecognised Undertreated Disabling Disorder (1996)Social Phobia in General Heal…Paroxetine in the Treatment of Generalized Social Phobia (1996)Paroxetine in the Treatment o…The Boundary of Social Phobia (1994)The Boundary of Social PhobiaPsychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine (1994)Psychopharmacological treatme…Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States (1994)Lifetime and 12-Month Prevale…Social Phobia (1992)Social PhobiaTherapeutic strategies for social anxiety disorder: where are we now? (2019)Therapeutic strategies for so…Pharmacotherapy for social anxiety disorder (SAnD) (2017)Pharmacotherapy for social an…A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators (2017)A meta-analysis of pharmacoth…Don't ask, don't tell: a systematic review of the extent to which participant characteristics are reported in social anxiety treatment studies (2016)Don't ask, don't tell: a syst…Generalized social anxiety disorder: A still‐neglected anxiety disorder 3 decades since Liebowitz's review (2015)Generalized social anxiety di…The evidence-based pharmacotherapy of social anxiety disorder (2012)The evidence-based pharmacoth…Evidence-based pharmacotherapy for personality disorders (2011)Evidence-based pharmacotherap…Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy (2009)Serotonin norepinephrine reup…Pharmacotherapy for social anxiety disorder: a systematic review (2008)Pharmacotherapy for social an…A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder (2007)A randomized controlled trial…Defining Response and Remission in Anxiety Disorders: Toward an Integrated Approach (2006)Defining Response and Remissi…Mirtazapine Treatment of Social Phobia in Women (2005)Mirtazapine Treatment of Soci…A Comparison of Clinical and Diagnostic Interview Schedule Diagnoses (1985)Prevalence and Incidence Studies of Anxiety Disorders: A Systematic Review of the Literature (2006)Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders (2014)Measurement of social-evaluative anxiety. (1969)Cognitive-behavioral group therapy versus phenelzine in social phobia: Long term outcome (1999)Barriers to the Treatment of Social Anxiety (2000)Evaluation of the Clinical Global Impression Scale among individuals with social anxiety disorder (2003)Diagnostic and Statistical Manual of Mental Disorders (2013)THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)Development of a Rating Scale for Primary Depressive Illness (1967)SCL-90: an outpatient psychiatric rating scale--preliminary report. (1973)Paroxetine in social phobia/social anxiety disorder (1999)Social Anxiety Disorder (2008)The Structured Clinical Interview for DSM-III-R (SCID) (1992)Antidepressants for the Treatment of Generalized Anxiety Disorder (1993)Impairment in Pure and Comorbid Generalized Anxiety Disorder and Major Depression at 12 Months in Two National Surveys (1999)Pregabalin for Treatment of Generalized Anxiety Disorder (2005)Current diagnosis and treatment of anxiety disorders. (2013)Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder (2018)The Hospital Anxiety and Depression Scale (1983)Paroxetine Treatment of Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled Study (2003)Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: an evidence-based treatment review (2018)Latent Structure Analysis. (1969)Social phobia in the general population: prevalence and sociodemographic profile (1999)Social phobia: overview of community surveys (2002)Epidemiology and natural course of social fears and social phobia (2003)The MOS Short-form General Health Survey (1988)The Validity and Reproducibility of a Work Productivity and Activity Impairment Instrument (1993)Comorbidity of Anxiety and Depressive Disorders: Issues in Conceptualization, Assessment, and Treatment (2004)Cognitive bias modification for anxiety: current evidence and future directions (2011)National Institute of Mental Health Diagnostic Interview Schedule (1981)The Structured Clinical Interview for DSM-III-R (SCID) (1992)Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence. (2003)Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication (2005)Agoraphobia, Simple Phobia, and Social Phobia in the National Comorbidity Survey (1996)Social Phobia (2015)Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD) (2018)Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis (2011)
this work references cited by second hop

References

  • 1994Lifetime and 12-Month Prevalence of DSM-III-R Psychiatric Disorders in the United States12,377 cited
  • 1992Social Phobia1,142 cited
  • 1998Social Phobia Subtypes in the National Comorbidity Survey398 cited
  • 1998Paroxetine Treatment of Generalized Social Phobia (Social Anxiety Disorder)348 cited
  • 1999Efficacy, Safety, and Tolerability of Venlafaxine Extended Release and Buspirone in Outpatients With Generalized Anxiety Disorder302 cited
  • 2000Efficacy of Venlafaxine Extended-Release Capsules in Nondepressed Outpatients With Generalized Anxiety Disorder295 cited
  • 1994Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine270 cited
  • 1999Fluvoxamine Treatment of Social Phobia (Social Anxiety Disorder): A Double-Blind, Placebo-Controlled Study263 cited
  • 2001Impact of Generalized Social Anxiety Disorder in Managed Care261 cited
  • 2000Efficacy of Extended-Release Venlafaxine in Nondepressed Outpatients With Generalized Anxiety Disorder252 cited
  • 2001Sertraline Treatment of Generalized Social Phobia: A 20-Week, Double-Blind, Placebo-Controlled Study224 cited
  • 1996Social Phobia in General Health Care: An Unrecognised Undertreated Disabling Disorder219 cited
  • 1994The Boundary of Social Phobia216 cited
  • 2001Venlafaxine Extended Release (ER) in the Treatment of Generalised Anxiety Disorder

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

175 cited
  • 1999The functional anatomy, neurochemistry, and pharmacology of anxiety.141 cited
  • 1996Paroxetine in the Treatment of Generalized Social Phobia135 cited
  • Cited by

    • 2012The evidence-based pharmacotherapy of social anxiety disorder98 cited
    • 2009Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy92 cited
    • 2017Pharmacotherapy for social anxiety disorder (SAnD)84 cited
    • 2011Evidence-based pharmacotherapy for personality disorders83 cited
    • 2005Mirtazapine Treatment of Social Phobia in Women80 cited
    • 2007A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder71 cited
    • 2008Pharmacotherapy for social anxiety disorder: a systematic review66 cited
    • 2019Therapeutic strategies for social anxiety disorder: where are we now?57 cited
    • 2006Defining Response and Remission in Anxiety Disorders: Toward an Integrated Approach52 cited
    • 2017A meta-analysis of pharmacotherapy for social anxiety disorder: an examination of efficacy, moderators, and mediators46 cited
    • 2015Generalized social anxiety disorder: A still‐neglected anxiety disorder 3 decades since Liebowitz's review40 cited
    • 2016Don't ask, don't tell: a systematic review of the extent to which participant characteristics are reported in social anxiety treatment studies12 cited